Genenta Science SPA (Genenta Science SPA) Other Current Liabilities : $0.28 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Other Current Liabilities?

Genenta Science SPA's other current liabilities for the quarter that ended in Dec. 2023 was $0.28 Mil.

Genenta Science SPA's quarterly other current liabilities declined from Dec. 2022 ($0.32 Mil) to Jun. 2023 ($0.23 Mil) but then increased from Jun. 2023 ($0.23 Mil) to Dec. 2023 ($0.28 Mil).

Genenta Science SPA's annual other current liabilities increased from Dec. 2021 ($0.11 Mil) to Dec. 2022 ($0.32 Mil) but then declined from Dec. 2022 ($0.32 Mil) to Dec. 2023 ($0.28 Mil).

Genenta Science SPA Other Current Liabilities Historical Data

The historical data trend for Genenta Science SPA's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Other Current Liabilities Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial				-	-	-	-	-

Genenta Science SPA Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Genenta Science SPA Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

K5F:Germany

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.